Xiling Lab
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $23M
Investors
- 8
About Xiling Lab
Established in 2016 and based in Chengdu, China. Xiling Lab is a biotechnology company that engages in the R&D, clinical trials, production, and commercialization of generic drugs and innovative drugs., LTD in Chengdu, and GUIXI PHARMATECH PTY LTD in Australia. Dr. Huang Jin Kun, the company's founder, is one of the main pioneers in the invention and application of the modern ruthenium carbene metathesis catalyst. Xiling Lab has more than 20 invention patents. Xiling Lab's products can be divided into innovative drug pipes, imaging agents, catalyst agents, and anti-tumor drugs. Innovative drugs are treated for gastrointestinal diseases, tumors, and ophthalmology diseases. Imaging agents include magnetic resonance (MRI) imaging agents and computed tomography (CT) imaging agents. Catalyst agents include Grubbs series catalyst agents, palladium catalyst agents, and ruthenium catalyst agents. Tumor drugs include Eribulinmesylate raw material drugs, DXD, antibody-drug conjugate (ADC), and intermediate raw material drugs.
Who invested in Xiling Lab
8 investors across 4 rounds
See all investors in Xiling Lab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xiling Lab
Who invested in Xiling Lab?
Xiling Lab has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xiling Lab raised?
Xiling Lab has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Xiling Lab last raise money?
Xiling Lab's most recent round on record is a Series A, in Aug 2021.
What does Xiling Lab do?
Established in 2016 and based in Chengdu, China.
Where is Xiling Lab headquartered?
Xiling Lab is headquartered in Chengdu, China.
Which VCs invest in companies like Xiling Lab?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Xiling Lab's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Xiling Lab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.